Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesDurable Medical Equipment (DME)Aetna pressure-reducing support surfaces Coverage …
    Ask Trek AI about this page
    CurrentAetnaPolicy 0430

    Pressure Reducing Support Surfaces

    Customize your policy alerts

    Sign up for Aetna Policy 0430 alerts

    Get alerted when Policy 0430 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity, coverage limitations, and coding for pressure-reducing support surfaces (mattress overlays, specialty mattresses, and specialty beds) as durable medical equipment for Aetna members.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerAetna
    PolicyPressure Reducing Support Surfaces
    Policy CodePolicy 0430
    Change TypeNo material changes
    Effective DateJun 12, 2001
    Last ReviewJun 19, 2023
    Next Review DateApr 25, 2024
    Key ActionObtain prior authorization for specialty beds and powered support surfaces and document medical necessity with a physician-ordered comprehensive assessment and care plan.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    3Support surface groups
    1 monthMin conservative trial
    60 daysPost-flap typical use
    MonthlyAir-fluidized recert
    06/19/2023Last review
    06/12/2001Effective (orig)

    Coverage Criteria for Support Surfaces

    inv-01: Group 1 Support Surfaces (medically necessary when...)

    Group 1 support surfaces are medically necessary when:

    Group1-pathways

    • a: Completely immobile — member cannot make changes in body position without assistance.
    • b_or_c

      • b: Limited mobility — member cannot independently make changes in body position significant enough to alleviate pressure.
      • c: Any stage pressure ulcer on trunk or pelvis.
    • d_to_g

      • d: Impaired nutritional status.
      • e: Fecal or urinary incontinence.
      • f: Altered sensory perception.
      • g: Compromised circulatory status.

    inv-02: Group 2 Support Surfaces (medical necessity pathways)

    Group 2 support surfaces (alternating pressure, low air loss) are medically necessary when ANY of the following pathways is met:

    Group2-pathways

    • path1: Member has multiple stage II pressure ulcers on the trunk or pelvis (a) AND has been on a comprehensive ulcer treatment program for at least the past month which included an appropriate Group 1 support surface (b) AND the member's ulcers have worsened or remained the same over the past month (c).
    • path2: Member has large or multiple stage III or stage IV pressure ulcer(s) on the trunk or pelvis (d).
    • path3

      • e: Recent myocutaneous flap or skin graft for a pressure ulcer on trunk or pelvis (surgery within past 60 days).

    inv-03: Group 3 (Air-fluidized bed) criteria

    Support surfaces are considered medically necessary when ALL of the features specified for the relevant group are met and when the medical necessity criteria for that group are satisfied.

    Group 1 support surfaces: Group 1 includes pressure pads for mattresses, non-powered pressure-reducing mattresses, and powered pressure-reducing mattress overlay systems. Required device features (examples): gel overlay height ≥2 in; water overlay filled height ≥3 in; air overlay cell height ≥3 in; foam overlay base thickness ≥2 in with peak height ≥3 in (convoluted) or overall ≥3 in (non-convoluted); durable waterproof cover; foam density adequate for pressure reduction. Non-powered mattresses: foam height ≥5 in or air/water/gel layer ≥5 in and must be placeable on a hospital bed frame. Powered overlays must include an air pump/blower providing sequential inflation or low interface pressure, adequate chamber height/proximity/cycling to provide patient lift and prevent bottoming out, and inflated cell height ≥2.5 in when cells are circulated.
    Group 2 support surfaces: Group 2 includes powered pressure-reducing mattresses, powered overlays/underlays, semi/total electric beds with powered mattresses, and advanced non-powered mattresses/overlays. Required device features include design to reduce friction/shear; pump/blower delivering sequential inflation or low interface pressure; compatibility with hospital bed frame; chamber height/proximity/frequency to provide lift and prevent bottoming out; inflated cell height ≥5 in for powered mattresses and ≥3.5 in for powered overlays/underlays; advanced non-powered products require documented evidence of effectiveness and total height thresholds (≥3 in for advanced overlays; ≥5 in for advanced mattresses).

    inv-05: Group-based medical necessity criteria

    Additional coverage rules, exclusions, and investigational statements:

    bottoming_out_exclusion: Support surfaces that allow bottoming out are not medically necessary.

    Bottoming out must be assessed per policy-specified test positions (supine flat, supine head elevated ≤30°, and side-lying).

    airfluidized_contraindications: Air-fluidized beds are investigational or may be denied when Group 3 criteria are not met or when contraindications are present, including: insufficient electrical system; inadequate structural support for the bed; caregiver unwilling/unable to provide required care; co-existing pulmonary disease; need for wet soaks or moist dressings not protected by an occlusive covering; or other known contraindications.

    These contraindications can preclude coverage.

    policy_limit_exclusions: Coverage of an air-fluidized bed is limited to the equipment itself; architectural adjustments (electrical or structural improvements) and services of informal caregivers are generally excluded from coverage.

    Check benefit plan descriptions for additional exclusions.

    Coverage for an air-fluidized bed is limited to the equipment itself. Architectural adjustments (for example, electrical upgrades or structural modifications to support the weight of an air-fluidized system) are generally excluded from coverage. In addition, services provided by informal caregivers related to air-fluidized bed setup or ongoing operation are excluded. Providers and suppliers should confirm specific plan benefit details in the member's benefit plan.

    Aetna does not cover ordinary air mattresses that are not designed as alternating-air or low-air-loss therapeutic devices because they do not meet Aetna's contractual definition of durable medical equipment. Examples of non-covered consumer-style products include the Air Flow Mat air-filled vibrating mattress and the Air-O-Pad air mattress.

    A support surface that fails to meet the specific dimensional and functional characteristics required by its assigned group will usually be considered not medically necessary. Products that are nonconforming to the policy's group definitions (including device construction, inflated cell or overall heights, pump/blower functionality, or other required features) may be denied as not meeting the policy criteria.

    Clinical Policy Bulletins are intended to assist with administration of plan benefits and provide a partial, general description of benefits. They do not constitute a contract or guarantee of coverage; specific benefit determinations depend on the member's benefit plan and on documentation that supports medical necessity. Policies may be updated and are subject to change.

    When the policy's medical necessity criteria for Group 1, 2 or 3 support surfaces are not met, the device (including air-fluidized beds) is considered experimental and investigational and therefore not covered. In addition, air-fluidized beds have no proven value for persons with listed contraindications (for example, inadequate electrical or structural support, caregiver inability, co-existing pulmonary disease, or need for wet soaks/moist dressings not protected by an occlusive covering), which can also preclude coverage.

    Support surfaces that permit bottoming out — defined by the policy as the ability to readily palpate the bony prominence between the undersurface of the overlay or mattress and the bony prominence when tested in specified positions — are considered not medically necessary and may be denied.

    Products that do not meet the policy-specified characteristics for their stated group (for example, required heights, functional pump/blower features, or construction criteria) will usually be considered not medically necessary and therefore not covered.

    Coding and Code Lists

    HCPCS codes covered if selection criteria are metHCPCSCovered
    A4640Replacement pad for use with medically necessary alternating pressure pad owned by patient
    E0181Powered pressure reducing mattress overlay/pad, alternating, with pump, includes heavy duty
    E0182Pump for alternating pressure pad, for replacement only
    E0183Powered pressure reducing underlay/pad, alternating, with pump, includes heavy duty
    E0184Dry pressure mattress
    E0185Gel or gel-like pressure pad for mattress, standard mattress length and width
    E0186Air pressure mattress
    E0187Water pressure mattress
    E0188Synthetic sheepskin pad
    E0189Lambswool sheepskin pad, any size
    1–10 of 22
    1/3
    ICD-10 codes covered if selection criteria are metICD-10Covered
    L89.101-L89.159Pressure ulcer of back
    L89.200-L89.229Pressure ulcer of hip
    L89.301-L89.329Pressure ulcer of buttock
    L89.40-L89.45Pressure ulcer of contiguous site of back, buttock and hip
    L89.810-L89.899Pressure ulcer of other site
    R40.0Somnolence
    R40.1Stupor
    R40.3Persistent vegetative state
    R40.4Transient alteration of awareness
    Z74.01Bed confinement status
    ICD-10 codes covered if selection criteria are metICD-10Covered
    I96Gangrene, not elsewhere classified
    L89.101-L89.159Pressure ulcer of back
    L89.200-L89.229Pressure ulcer of hip
    L89.301-L89.329Pressure ulcer of buttock
    L89.40-L89.45Pressure ulcer of contiguous site of back, buttock and hip
    R64Cachexia
    Z74.01Bed confinement status
    Air-fluidized beds (HCPCS) covered if selection criteria are metHCPCSCovered
    E0194Air fluidized bed
    ICD-10 codes often associated with air-fluidized bed coverageICD-10Covered
    I96Gangrene, not elsewhere classified
    R64Cachexia
    ICD-10 codes covered if selection criteria are metICD-10Covered
    L89.101-L89.159Pressure ulcer of back
    L89.200-L89.229Pressure ulcer of hip
    L89.301-L89.329Pressure ulcer of buttock
    L89.40-L89.45Pressure ulcer of contiguous site of back, buttock and hip
    Z74.01Bed confinement status
    ICD-10 codes covered if selection criteria are met (additional)ICD-10Covered
    R64Cachexia
    ICD-10 codes listed as not-covered for certain indicationsICD-10Not Covered
    J40-J47.9Chronic lower respiratory diseases
    J86.0-J94.9Other pleural/pulmonary diseases (examples listed)
    J96.00-J99Other diseases of respiratory system
    L89.500-L89.629Pressure ulcer of ankle or heel (listed as not covered for indications in CPB)
    ICD-10 codes (continued)ICD-10Not Covered
    M86.071Osteomyelitis and related codes (see policy appendix for full list)
    M86.079Osteomyelitis (see policy appendix)
    M86.171-M86.179Osteomyelitis codes
    M86.271-M86.279Osteomyelitis codes
    M86.371-M86.379Osteomyelitis codes
    M86.471-M86.479Osteomyelitis codes
    M86.571-M86.579Osteomyelitis codes
    M86.671-M86.679Osteomyelitis codes
    M86.8x7Osteomyelitis codes
    M86.9Osteomyelitis, unspecified
    1–10 of 12
    1/2
    Ulcer size/location concern for air-fluidized bed justification
    Physician documentation required for small/non-posterior ulcersIf an air-fluidized bed is requested and the ulcer is < 8 square centimeters and/or located outside the posterior trunk or pelvis, the attending physician must document why an alternative support surface would not be medically effective.
    Ulcer size threshold8 square centimeters - ulcers smaller than this on non-posterior trunk/pelvis require justification.
    Location emphasisPosterior trunk or pelvis are the primary locations for standard air-fluidized bed indications; other locations need physician rationale.
    Inflated cell height thresholds specified across groups
    Group 1 — inflated cell height

    Provider Actions and Operational Rules

    Denial Risk

    Air-fluidized bed contraindications

    An air-fluidized bed is contraindicated and considered to have no proven value when any of the following conditions exist: inadequate electrical system for increased energy consumption; inadequate structural support (systems may weigh ~1,600 pounds or more); caregiver unwilling or unable to provide required care; co-existing pulmonary disease that impairs effective coughing or worsens secretions; need for wet soaks or moist wound dressings that cannot be made impervious; or other known contraindications to air-fluidized bed use.

    • Electrical system insufficient for anticipated increased energy consumption
    • Structural support inadequate to support air-fluidized bed weight
    • Caregiver unwilling/unable to provide required care
    • Co-existing pulmonary disease (ineffective cough, thickened secretions)
    • Requires wet soaks or moist dressings not protected by occlusive covering
    • Any other documented contraindication to air-fluidized bed use
    Note

    Medical Necessity Mapping and Evidence

    inv-42: DME medical necessity mapping to equipment groups (Group 1/2/3 summary)

    DME medical necessity mapping to equipment groups — select equipment consistent with the group-based clinical criteria and device feature requirements:

    Group1-summary: Group 1 devices: appropriate for members who meet Group 1 clinical criteria (completely immobile OR limited mobility/any stage ulcer plus ≥1 risk factor). Device selection must meet the dimensional and functional thresholds for Group 1 (see device feature compliance).
    Group2-summary: Group 2 devices: reserved for members who meet one of the Group 2 clinical pathways (refractory multiple stage II after ≥1 month comprehensive care including Group 1; large/multiple stage III/IV; recent flap/graft or recent discharge following Group 2/3 use). Devices must meet Group 2 feature thresholds (inflated cell heights, pump functionality, anti-bottoming design).
    Group3-summary: Group 3 devices (air-fluidized beds): require meeting all Group 3 clinical criteria (stage III/IV truncal/pelvic ulcers except foot-alone, bedridden/chairbound, would require institutionalization without bed, prior conservative treatment tried ≥1 month with worsening/no improvement unless other conditions apply; caregiver availability; physician monthly recertification; alternatives considered).

    Rental, Purchase, and Specific Device Notes

    EquipmentRental vs Purchase Rule
    Air‑fluidized beds (Group 3)Not specified in this excerpt; policy states coverage is limited to the equipment itself and architectural adjustments and informal caregiver services are generally excluded (see policy limitations). Specific rental vs purchase instructions are not provided in the cited segments.
    Specialty mattresses/overlays (Group 1 and Group 2 devices)Not specified in this excerpt; HCPCS codes for these devices are listed, but the document does not provide rental versus purchase rules in the provided segments.
    EquipmentRental vs Purchase Rule
    Dolphin Bed / fluid immersion systemsNot specified in this excerpt; background describes device features and clinical/cost alternative role to air‑fluidized therapy but does not specify rental versus purchase rules.
    Policy MetadataRental vs Purchase Rule (excerpt status)
    Policy number: 0430; Effective date: 06/12/2001; Last review: 06/19/2023; Next review: 04/25/2024Not specified in the provided excerpt — the document notes that rental vs purchase rules are not included in these segments.
    HCPCS codes and device lists present (see coding section for covered codes)No rental/purchase guidance present in cited excerpts; equipment coverage focus and HCPCS listing are provided but rental vs purchase rules are absent.

    Replacement Parts and Accessories

    Replacement pads, pumps (replacement guidance not specified)
    Replacement parts listedReplacement pumps (E0182) and replacement pads (A4640) are included among HCPCS codes in the policy, indicating replacement items are recognized.
    Replacement interval informationThe policy lists replacement pads and pumps but does not specify replacement intervals or schedules in the excerpt.
    Coding for replacement itemsSpecific HCPCS codes for replacement components are A4640 (replacement pad) and E0182 (pump - replacement only).
    Policy placeholder — no contentNo replacement metadata provided in this excerpt; section reserved for replacement scheduling or intervals if specified elsewhere.
    Review/updatesPolicy last reviewed 06/19/2023; any replacement guidance changes would be reflected in future reviews.

    Required Documentation and Records

    Documentation Required

    Submit written physician order and supporting documentation for specialty beds and Group 2/3 devices

    Include a written physician order based on a comprehensive assessment and provide supporting documentation of prior conservative treatments, care plan, and device feature compliance when requesting specialty beds (air-fluidized) or for demonstrating medical necessity for Group 2/3 devices.

    • Written order must be based on assessment and evaluation (generally within 1 week prior to initiation for air-fluidized beds).
    • Provide evidence of prior conservative treatment (typically ≥1 month) and the documented care plan.
    Documentation Required

    Document required care plan elements in the medical record

    Document the care plan elements in the medical record: moisture/incontinence management, turning and positioning, wound care for stage II–IV ulcers, patient/caregiver education on prevention/management, nutritional assessment/intervention, and regular licensed assessments.

    • If member is on a Group 2 surface, the care plan should be established by the physician or home care nurse and include these elements.

    Not Covered Items and Exclusions

    Ordinary air mattresses that are not alternating-air or low-air-loss therapeutic devices (i.e., consumer-style air mattresses) and architectural modifications necessary to install/operate an air-fluidized bed are not covered under the policy. Refer to the policy exclusions for examples and check the member's benefit plan for additional details.

    Examples of air mattresses specifically identified as not covered include the Air Flow Mat air-filled vibrating mattress and the Air-O-Pad air mattress; these ordinary air mattresses do not meet the DME definition used by the plan.

    Support surfaces that do not meet the policy's stated characteristics for any group (i.e., nonconforming products) are usually considered not medically necessary and are not covered.

    As noted elsewhere in the policy, consumer-style air mattresses that are not therapeutic alternating-air or low-air-loss systems are excluded from coverage. See the policy exclusions for the listed examples of ordinary air mattresses that are not covered.

    Background and Policy Scope

    Pressure-relieving support surfaces are designed to conform to body contours and distribute pressure over a larger area to prevent or promote healing of pressure ulcers. Selection among alternating-air, low-air-loss, and air-fluidized systems is informed by guidelines and evidence, but comparative efficacy among advanced surfaces is limited; higher-cost devices are therefore reserved for more severe or refractory ulcers.

    Defined Terms

    Completely immobile
    DefinitionCompletely immobile: member cannot make changes in body position without assistance.
    Usage in criteriaListed as criterion 'a' for Group 1 support surface medical necessity (alone can meet Group 1 indication).
    ImplicationIndicates patient requires a support surface when independent repositioning is impossible.
    Limited mobility
    DefinitionLimited mobility: member cannot independently make changes in body position significant enough to alleviate pressure.
    Role in Group 1 criteriaAppears as criterion 'b' — when combined with at least one additional risk factor it can meet Group 1 medical necessity.

    Evidence Informing Policy and References

    inv-44: Evidence informing necessity (systematic reviews cited such as Cochrane, Tricco, Colin, McInnes)

    Key systematic reviews and evidence sources cited in the policy include:

    Cochrane-and-overviews: Tricco et al. (overview of systematic reviews) and other systematic reviews and evidence summaries are cited to inform the policy (see Tricco et al., BMC Med. 2015 and other referenced reviews).

    References: Tricco (chunk 37) and related systematic reviews listed in the references section (chunks 36–37).

    Additional-reviews: Other cited evidence includes Medicare LCDs, CRD Effective Health Care review, JAMA systematic reviews, randomized evaluations (e.g., PRESSURE trial), and WOCN guidelines which collectively inform device-group recommendations and the stepwise escalation approach.

    See policy references (chunks 36–37).

    Policy Dates and Revision History

    2023-06-19policy_reviewLatest

    Policy last reviewed on 06/19/2023; review entry recorded in policy history.

    2001-06-12effective_date

    Policy effective date established as 06/12/2001.

    2024-04-25next_review_scheduled

    Next policy review scheduled for 04/25/2024 (as noted in policy metadata).

    Policy Summary
    PayerAetna
    PolicyPressure Reducing Support Surfaces
    Policy CodePolicy 0430
    Change TypeNo material changes
    Effective DateJun 12, 2001
    Last ReviewJun 19, 2023
    Next Review DateApr 25, 2024
    Key ActionObtain prior authorization for specialty beds and powered support surfaces and document medical necessity with a physician-ordered comprehensive assessment and care plan.
    SourceLink
    On This Page
    Coverage Criteria for Support SurfacesCoding and Code ListsProvider Actions and Operational RulesMedical Necessity Mapping and EvidenceRental, Purchase, and Specific Device NotesReplacement Parts and AccessoriesRequired Documentation and RecordsNot Covered Items and ExclusionsBackground and Policy ScopeDefined TermsEvidence Informing Policy and ReferencesPolicy Dates and Revision History
    f: Member was on a Group 2 or 3 support surface immediately prior to recent discharge from hospital or nursing facility (discharge within past 30 days).
    Group 3 support surfaces: Group 3 includes air-fluidized beds (bead beds) that use warm air to fluidize ceramic beads to distribute body weight. These are medically necessary only when the Group 3 clinical criteria are met.
    Inflated cell height (when air cells are circulated) is 2.5 inches or greater.
    Group 2 — powered mattresses inflated cell heightInflated cell height of air cells through which air is being circulated is 5 inches or greater for powered pressure-reducing mattresses.
    Group 2 — powered overlays/underlays inflated cell heightInflated cell height of air cells through which air is being circulated is 3.5 inches or greater for powered overlays/underlays.

    Policy update and coverage risk notice

    Coverage for an air-fluidized bed is limited to the equipment itself. Architectural, structural, or electrical improvements needed to accommodate the bed and services of informal caregivers are generally excluded. Providers should verify member benefits and limitations against the member's plan; changes to coverage criteria may occur and could affect medical necessity determinations.

    • Architectural adjustments (electrical/structural) generally excluded from coverage
    • Services of informal caregivers excluded — check benefit plan descriptions
    • Verify plan-specific limits and recent policy updates prior to ordering
    Prior Authorization

    Air-fluidized bed assessment and recertification

    An air-fluidized bed must be ordered in writing by the attending physician based on a comprehensive assessment and evaluation after a conservative treatment program has been tried without success. The evaluation generally must be performed within one week prior to initiation of therapy. The physician must direct the home treatment regimen and reevaluate and recertify medical necessity on a monthly basis.

    • Physician-ordered comprehensive assessment within 1 week prior to initiation
    • Conservative treatment trial (generally ≥1 month) documented as tried and failed
    • Monthly physician reevaluation and recertification required for continued coverage
    Documentation Required

    Comprehensive ulcer treatment documentation requirement

    The comprehensive ulcer treatment program should be documented in the medical record and generally include moisture/incontinence management, turning and positioning, appropriate wound care for stage II–IV ulcers, patient and caregiver education, nutritional assessment/intervention, and regular assessment by a licensed practitioner (usually at least weekly for stage III/IV ulcers). If on a group 2 surface, a physician-or home-care-nurse established care plan must be present.

    • Moisture/incontinence management
    • Turning and positioning
    • Appropriate wound care (stage II–IV)
    • Education for patient and caregiver
    • Nutritional assessment and intervention
    • Regular assessment by nurse/physician/licensed practitioner (usually ≥ weekly for stage III/IV)
    • If on group 2 surface, physician/home care nurse-established care plan required
    Documentation Required

    Care plan documentation required

    Patients using pressure-reducing support surfaces must have a documented care plan established by the physician and home care nurse in the medical record. The care plan should include the comprehensive ulcer treatment elements, and evidence that other aspects of the plan are modified when healing does not continue or documentation that continued use of the device is medically necessary for wound management.

    • Care plan documented by physician and home care nurse in medical records
    • Includes comprehensive ulcer treatment elements
    • Documentation when continued device use is required or other care plan modifications are being made
    Note

    Group-based device categorization

    Support surfaces are categorized by group based on the clinically predominant component (usually the topmost layer). Examples: Group 2 includes powered pressure-reducing mattresses, advanced non-powered overlays (with defined performance features); Group 3 includes air-fluidized beds. Providers must select devices using the group definitions and ensure the product meets the required device characteristics for that group.

    • Group 2: powered pressure-reducing mattresses, semi/total electric hospital beds with powered mattresses, advanced non-powered overlays that meet listed features
    • Group 3: air-fluidized beds (e.g., Clinitron)
    • Multi-component products are categorized by clinically predominant component
    Note

    Escalation pathway and provider responsibilities

    If device selection, clinical documentation, or prior-authorization requirements are unclear or a denial is received, follow the payer's escalation and appeal pathways promptly. Document all clinical rationale, responses to additional information requests, and any modifications to the care plan. Verify device characteristics against policy criteria before submission to avoid delays.

    • Follow payer escalation/appeal processes if prior auth denied or additional information requested
    • Document clinical rationale and care-plan modifications when appealing
    • Confirm device characteristics meet policy criteria before ordering/submission

    inv-43: Device feature compliance (device must meet all feature requirements for its assigned group)

    Device feature compliance — a device must meet all feature requirements for its assigned group to be considered medically necessary:

    Feature compliance: Device must meet the explicit dimensional and functional thresholds listed for its group (examples: gel overlay ≥2 in; water overlay ≥3 in; Group 1 powered overlay inflated cell height ≥2.5 in; Group 2 powered mattress inflated cell height ≥5 in; Group 2 powered overlay/underlay inflated cell height ≥3.5 in; advanced non-powered product total heights ≥3–5 in as specified). Devices must include required components (pump/blower with sequential inflation or low interface pressure where applicable), be compatible with hospital bed frames as specified, have design features to reduce friction/shear, and prevent bottoming out. Nonconforming products are usually considered not medically necessary.

    inv-44: Evidence informing necessity (systematic reviews and studies cited)

    Evidence informing medical necessity determinations — systematic reviews, randomized trials, guidelines and policy references cited in the policy inform coverage decisions (evidence does not create alternate eligibility pathways):

    Evidence base: Policy cites systematic reviews and other evidence sources (e.g., Medicare LCDs, CRD review, JAMA systematic review, randomized trials and WOCN guideline) to inform selection of support surfaces and to justify reserving higher-cost devices for severe or refractory ulcers. Specific evidence references are listed in the policy reference section (see references).

    See references cited in policy (chunks 36–37).

    Action for providersRefer to the full policy or plan-specific prior authorization requirements for replacement timing and coverage rules.
  1. Regular assessments (usually at least weekly for stage III/IV ulcers) should be documented.
  2. Documentation Required

    Provide supporting medical records and justification per plan requirements

    Provide the plan with supporting medical records and justification to substantiate medical necessity and adherence to policy requirements when requesting coverage or prior authorization; Clinical Policy Bulletins are guidance and do not replace required documentation.

    • Include clinical notes, wound measurements, documentation of conservative treatments, care plan, and device specifications.
    • Demonstrate that all alternative equipment have been considered and ruled out when required.
    Clinical implicationPatient may need assisted repositioning or enhanced support surface to reduce pressure injury risk.
    Bottoming out
    DefinitionBottoming out: an outstretched hand can readily palpate the bony prominence between the undersurface of the overlay or mattress and the bony prominence (tested supine flat, supine with head ≤30° elevation, and sidelying).
    Coverage consequenceSupport surfaces that allow bottoming out are considered not medically necessary.
    Assessment positionsTest in supine (head flat), supine (head elevated ≤30°), and sidelying positions per policy description.
    Pressure ulcer staging
    Stage INon-blanchable erythema of intact skin.
    Stage IIPartial-thickness skin loss involving epidermis and/or dermis.
    Stage IIIFull-thickness skin loss involving damage or necrosis of subcutaneous tissue that may extend down to, but not through, underlying fascia.
    Stage IVFull-thickness skin loss with extensive destruction, tissue necrosis or damage to muscle, bone, or supporting structures.
    Air-fluidized bed (Group 3)
    DefinitionAir-fluidized bed (Group 3): a mattress using warm air under pressure to set small ceramic beads in motion, simulating fluid movement and distributing body weight broadly to create a 'floating' sensation.
    Group 3 indication summaryAir-fluidized beds are considered Group 3 support surfaces and are medically necessary only when Group 3 criteria are met (see policy).
    Examples/brandsExamples of Group 3 air-fluidized beds include Clinitron, Fluid Air, and Mediscus Heavy Duty System.
    Definition placeholder — no term providedThis definition entry is blank in the provided excerpt and reserved for any additional defined term if included in the full policy.
    ActionRefer to the full policy definitions page for any missing or additional terminology.
    Policy metadataPolicy last reviewed 06/19/2023; effective date 06/12/2001.